University of Iowa
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1847-02-25
- Employees
- 251
- Market Cap
- -
- Website
- http://www.uiowa.edu
Randomized Trial Of Tinnitus Retraining Therapy
- First Posted Date
- 2007-12-20
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 180
- Registration Number
- NCT00578058
- Locations
- ๐บ๐ธ
University of Michigan, Ann Arbor, Michigan, United States
๐บ๐ธEast Tennessee State University, Johnson City, Tennessee, United States
๐บ๐ธUniversity of Iowa, Iowa City, Iowa, United States
Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2017-02-20
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 3
- Registration Number
- NCT00574470
- Locations
- ๐บ๐ธ
University of Iowa Hospitals, Iowa City, Iowa, United States
Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 50
- Registration Number
- NCT00574964
- Locations
- ๐บ๐ธ
Holden Comprehensive Cancer Clinic, Iowa City, Iowa, United States
Acamprosate in the Treatment of Pathological Gambling
- First Posted Date
- 2007-12-11
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 26
- Registration Number
- NCT00571103
Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-11-29
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 150
- Registration Number
- NCT00565305
- Locations
- ๐บ๐ธ
Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, United States
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-08-09
- Last Posted Date
- 2014-08-19
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 954
- Registration Number
- NCT00513903
- Locations
- ๐บ๐ธ
The University of Iowa, Iowa City, Iowa, United States
Efficacy and Safety of Omalizumab in Bullous Pemphigoid
- First Posted Date
- 2007-05-10
- Last Posted Date
- 2012-10-16
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 2
- Registration Number
- NCT00472030
- Locations
- ๐บ๐ธ
University of Iowa, Department of Dermatology, Iowa City, Iowa, United States
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-01-24
- Last Posted Date
- 2017-12-29
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 2
- Registration Number
- NCT00426127
- Locations
- ๐บ๐ธ
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Oral Cleft Prevention Program
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-11-10
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 4000
- Registration Number
- NCT00397917
- Locations
- ๐บ๐ธ
University of Iowa, Iowa City, Iowa, United States
Atomoxetine and Huntington's Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2012-12-20
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 20
- Registration Number
- NCT00368849
- Locations
- ๐บ๐ธ
The University of Iowa, Iowa City, Iowa, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath